Odhaib Samih A, Alhumrani Abdul Raheem
Adult Endocrinology, Faiha Specialized Diabetes, Endocrine and Metabolism Center, College of Medicine, University of Basrah, Basrah, IRQ.
Internal Medicine, College of Medicine, University of Basrah, Basrah, IRQ.
Cureus. 2020 Mar 23;12(3):e7373. doi: 10.7759/cureus.7373.
Background Red cell distribution width (RDW) reflects the volumetric heterogeneity of red blood cells (RBCs) and has proven to be a prognostic predictor for cardiovascular (CV) morbidity and mortality in ST-elevation myocardial infarction (STEMI). The study aims to evaluate the effect of the RDW admission value on the outcome of patients with STEMI. Materials and methods This is a cross-sectional observational study on (207) patients with first-ever STEMI, grouped according to their baseline RDW and thrombolysis eligibility into two groups. We calculated the in-hospital Global Registry of Acute Coronary Events (GRACE) score within 48 hours of presentation. Results The study demonstrated the impact of RDW on the primary STEMI outcomes (left ventricular ejection fraction (LVEF%), ST-resolution, arrhythmias, and cardiovascular mortality risk). It was nearly a gender-matched study, with a mean RDW of 14.20±1.86%. RDW>14% and age≥65 years were the strongest statistically significant independent predictors of STEMI outcome with LVEF % < 45%, ST-resolution, and CV mortality regardless of thrombolysis. The thrombolysis offers a logical significant negative relation with CV mortality. At the same time, hypertension, diabetes mellitus (DM), and smoking may cause an additional mortality burden, especially in elderly patients with high RDW who are not eligible for thrombolysis. There was a significant association between high GRACE to high RDW, with excellent specificity and sensitivity in predicting CV outcome. Conclusion The RDW is a simple to acquire index, with a good prognostic prediction of major adverse cardiovascular events (MACEs) and CV mortality in the STEMI patients. It is excellent in predicting STEMI outcomes, especially the response to thrombolysis.
背景 红细胞分布宽度(RDW)反映红细胞(RBC)的体积异质性,并且已被证明是ST段抬高型心肌梗死(STEMI)患者心血管(CV)发病和死亡的预后预测指标。本研究旨在评估RDW入院值对STEMI患者预后的影响。材料与方法 这是一项对207例首次发生STEMI患者的横断面观察性研究,根据其基线RDW和溶栓 eligibility分为两组。我们在就诊后48小时内计算了院内急性冠状动脉事件全球注册(GRACE)评分。结果 该研究证明了RDW对主要STEMI结局(左心室射血分数(LVEF%)、ST段回落、心律失常和心血管死亡风险)的影响。这几乎是一项性别匹配的研究,平均RDW为14.20±1.86%。无论是否进行溶栓,RDW>14%且年龄≥65岁是STEMI结局(LVEF%<45%、ST段回落和CV死亡率)最强的统计学显著独立预测因素。溶栓与CV死亡率呈逻辑上显著的负相关。同时,高血压、糖尿病(DM)和吸烟可能会导致额外的死亡负担,尤其是在不符合溶栓条件的高RDW老年患者中。高GRACE与高RDW之间存在显著关联,并在预测CV结局方面具有出色的特异性和敏感性。结论 RDW是一个易于获取的指标,对STEMI患者的主要不良心血管事件(MACE)和CV死亡率具有良好的预后预测作用。它在预测STEMI结局方面表现出色,尤其是对溶栓的反应。